Biotage AB Nomination Committee

A Nomination Committee consisting of shareholder representatives and the
Chairman of the Board of Directors has been formed for Biotage AB. The
Nomination Committee shall, before the Annual General Meeting 2013, prepare
proposals for the election of Chairman and other members of the Board of
Directors, the election of Chairman of the Annual General Meeting, election of
Auditors, the determination of fees and matters pertaining thereto.

The members of the Nomination Committee are:

Staffan Josephson, Investor Growth Capital, chairman

Anders Walldov, Brohuvudet AB and direct holding

Jesper Bonnevier, Länsförsäkringar Fonder

Ove Mattsson, Chairman of the Board, holding by endowment insurances

Shareholders wishing to submit a proposal for members of the Board of Directors
may do so by sending e-mail to the Chairman of the Board of Directors of Biotage
AB at: info@biotage.com

Contact:
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84, torben.jorgensen@biotage.com



Biotage discloses the information provided herein pursuant to the Swedish
Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The
information was submitted for publication at 08.00 on 16 October 2012.



About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical
chemistry and medicinal chemistry. The customers include the world’s largest
pharmaceutical and biotech companies, and leading academic institutes. The
company is headquartered in Uppsala and has offices in the US, UK, China and
Japan. Biotage has 270 employees and had sales of 428.4 MSEK in 2011. Biotage is
listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website:
www.biotage.com